InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Moreland Mary K, Chairman & CEO. Insider active across 1 companies, notably Abbott Laboratories. In total, 4 disclosures have been published. The latest transaction was filed on 28 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€450,1814,112 shares@ €109.47980.0002% mcap63.9% of flow
Common shares without par value
SEC:0001415889-22-002197:0·
015,813 shares0
Common shares without par value
SEC:0001415889-22-001742:0·
€126,9231,245 shares@ €101.94620.0001% mcap100.0% of flow
Common shares without par value
SEC:0001415889-21-003773·
€126,9231,245 shares@ €101.94620.0001% mcap18.0% of flow
Common shares without par value
SEC:0001415889-21-003773:0·
4 of 4 declarations
About Moreland Mary K
Mary K Moreland is the President and CEO of Abbott Laboratories. She oversees the company's overall operations, which is a global leader in healthcare. Mary K Moreland is responsible for implementing the company's growth strategy and innovation in products and services. Her leadership is essential for maintaining Abbott's market position and meeting customer needs.
